New Promising Therapeutic Modalities for Thyroid Cancers: Histone Deacetylase Inhibitor, PPAR-gamma Agonist, and Retinoic Acid

Ppar Gamma ◽

Thyroid Cancers ◽

Therapeutic Modalities ◽

Deacetylase Inhibitor ◽

Ppar Gamma Agonist

Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours

British Journal of Cancer ◽

10.1038/bjc.2011.527 ◽

2011 ◽

Vol 106 (1) ◽

pp. 77-84 ◽

Cited By ~ 101

Author(s):

R Pili ◽

B Salumbides ◽

M Zhao ◽

S Altiok ◽

D Qian ◽

...

Keyword(s):

Retinoic Acid ◽

Phase I ◽

Histone Deacetylase ◽

Phase I Study ◽

Solid Tumours ◽

Abstract 4078: Antitumor effect of the histone deacetylase inhibitor MS-275 in combination with retinoic acid Am80 in human cutaneous T-cell lymphoma

10.1158/1538-7445.am2012-4078 ◽

2012 ◽

Author(s):

Yukihiko Kato ◽

Chizu Egusa ◽

Tatsuo Maeda ◽

Ryoji Tsuboi

Keyword(s):

Retinoic Acid ◽

T Cell ◽

Histone Deacetylase ◽

Antitumor Effect ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Cutaneous T Cell Lymphoma ◽

Retinoic Acid and Histone Deacetylase Inhibitor BML-210 Inhibit Proliferation of Human Cervical Cancer HeLa Cells

Annals of the New York Academy of Sciences ◽

10.1196/annals.1378.079 ◽

2006 ◽

Vol 1091 (1) ◽

pp. 346-355 ◽

Cited By ~ 14

Author(s):

VERONIKA V. BORUTINSKAITE ◽

RUTA NAVAKAUSKIENE ◽

KARL-ERIC MAGNUSSON

Keyword(s):

Cervical Cancer ◽

Retinoic Acid ◽

Histone Deacetylase ◽

Hela Cells ◽

Deacetylase Inhibitor ◽

Human Cervical Cancer

The Histone Deacetylase Inhibitor FK228 Distinctly Sensitizes the Human Leukemia Cells to Retinoic Acid-Induced Differentiation

Annals of the New York Academy of Sciences ◽

10.1196/annals.1378.081 ◽

2006 ◽

Vol 1091 (1) ◽

pp. 368-384 ◽

Cited By ~ 16

Author(s):

JURATE SAVICKIENE ◽

GRAZINA TREIGYTE ◽

VERONIKA BORUTINSKAITE ◽

RUTA NAVAKAUSKIENE ◽

KARL-ERIC MAGNUSSON

Keyword(s):

Retinoic Acid ◽

Histone Deacetylase ◽

Leukemia Cells ◽

Human Leukemia ◽

Induced Differentiation ◽

Human Leukemia Cells ◽

Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanoma

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-06-0125 ◽

2007 ◽

Vol 6 (1) ◽

pp. 70-81 ◽

Cited By ~ 49

Author(s):

Yukihiko Kato ◽

Brenda C. Salumbides ◽

Xiao-Fei Wang ◽

David Z. Qian ◽

Simon Williams ◽

...

Keyword(s):

Retinoic Acid ◽

Malignant Melanoma ◽

Histone Deacetylase ◽

Antitumor Effect ◽

Human Malignant Melanoma ◽

Antineoplastic action of 5-aza-2′-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor β and estrogen receptor α genes in breast carcinoma cells

Cancer Chemotherapy and Pharmacology ◽

10.1007/s002800100294 ◽

2001 ◽

Vol 48 (1) ◽

pp. 71-76 ◽

Cited By ~ 93

Author(s):

Veronica Bovenzi ◽

Richard Momparler

Keyword(s):

Estrogen Receptor ◽

Retinoic Acid ◽

Breast Carcinoma ◽

Histone Deacetylase ◽

Retinoic Acid Receptor ◽

Estrogen Receptor Α ◽

Carcinoma Cells ◽

Breast Carcinoma Cells ◽

Molecular profiling of embryonal carcinoma cells following retinoic acid or histone deacetylase inhibitor treatment

Cancer Biology & Therapy ◽

10.4161/cbt.3.11.1190 ◽

2004 ◽

Vol 3 (11) ◽

pp. 1109-1120 ◽

Cited By ~ 29

Author(s):

Niquiche Sangster-Guity ◽

Li-Ming Yu ◽

Paulette McCormick

Keyword(s):

Retinoic Acid ◽

Histone Deacetylase ◽

Embryonal Carcinoma ◽

Molecular Profiling ◽

Carcinoma Cells ◽

Embryonal Carcinoma Cells ◽

Deacetylase Inhibitor ◽

Inhibitor Treatment

Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans retinoic acid

British Journal of Haematology ◽

10.1046/j.1365-2141.2000.01933.x ◽

2000 ◽

Vol 108 (4) ◽

pp. 696-702 ◽

Cited By ~ 64

Author(s):

Kunio Kitamura ◽

Shinetsu Hoshi ◽

Mitsuru Koike ◽

Hitoshi Kiyoi ◽

Hidehiko Saito ◽

...

Keyword(s):

Retinoic Acid ◽

Arsenic Trioxide ◽

Histone Deacetylase ◽

Acute Promyelocytic Leukaemia ◽

Promyelocytic Leukaemia ◽

Trans Retinoic Acid ◽

All Trans Retinoic Acid ◽

The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells

Leukemia ◽

10.1038/sj.leu.2403773 ◽

2005 ◽

Vol 19 (7) ◽

pp. 1161-1168 ◽

Cited By ~ 42

Author(s):

M R Trus ◽

L Yang ◽

F Suarez Saiz ◽

L Bordeleau ◽

I Jurisica ◽

...

Keyword(s):

Valproic Acid ◽

Retinoic Acid ◽

Histone Deacetylase ◽

Acute Myeloblastic Leukemia ◽

Leukemia Cells ◽

Trans Retinoic Acid ◽

All Trans Retinoic Acid ◽

Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptorβ2, via histone acetylation

Journal of Dermatological Science ◽

10.1016/j.jdermsci.2015.10.016 ◽

2016 ◽

Vol 81 (1) ◽

pp. 17-25 ◽

Cited By ~ 5

Author(s):

Yukihiko Kato ◽

Chizu Egusa ◽

Tatsuo Maeda ◽

Ryoji Tsuboi

Keyword(s):

Retinoic Acid ◽

T Cell ◽

Tumor Suppressor ◽

Histone Acetylation ◽

Histone Deacetylase ◽

Cell Lymphoma ◽

Suppressor Gene ◽

Cutaneous T Cell Lymphoma ◽